Related Experiment Videos
Gene therapy for pancreatic cancer--current and prospective strategies
C M Halloran1, P Ghaneh, J P Neoptolemos
1Department of Surgery, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby Street, Liverpool, L69 3GA, UK. halloran@liverpool.ac.uk
Abstract:
Pancreatic ductal adenocarcinoma is one of the most common causes of cancer death in the developed world. Long-term survival is currently only achieved through surgical resection. Most patients have locally advanced or metastatic disease at the time of diagnosis and are therefore not amenable to resection, whilst chemotherapy and radiotherapy are by and large ineffective. Gene therapy offers an alternative to current adjuvant strategies. With approximately two-thirds of all gene therapy trials worldwide directed at cancer, the gene therapy approaches that are currently being explored for pancreatic cancer are specifically examined. Gene delivery systems, genetic targets, and combined gene delivery with chemotherapy are discussed in the context of pancreatic cancer treatment.
Insights
Gene therapy offers a promising alternative for treating pancreatic cancer when surgery is not an option. This review examines current gene therapy approaches for pancreatic cancer, including delivery systems and targets.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Pancreatic ductal adenocarcinoma is a leading cause of cancer mortality globally.
- Surgical resection is the only curative option, but most patients present with unresectable disease.
- Current chemotherapy and radiotherapy offer limited efficacy for advanced pancreatic cancer.
Purpose of the Study:
- To review current gene therapy strategies for pancreatic cancer.
- To examine gene delivery systems and genetic targets in pancreatic cancer research.
- To discuss the potential of combining gene therapy with chemotherapy.
Main Methods:
- Literature review of gene therapy trials for pancreatic cancer.
- Analysis of gene delivery systems and targets.
- Evaluation of combination strategies with chemotherapy and radiotherapy.
Main Results:
- Gene therapy is a significant focus of cancer research, with many trials underway.
- Various gene delivery systems and specific genetic targets are being explored for pancreatic cancer.
- Combination approaches show potential for enhanced therapeutic effects.
Conclusions:
- Gene therapy presents a viable alternative for patients with unresectable pancreatic cancer.
- Further research into optimized gene delivery and targeting is crucial.
- Combined gene therapy and chemotherapy may improve treatment outcomes for pancreatic cancer.